PAVmed Q4 EPS $(0.15) Beats $(0.25) Estimate, Sales $112.00K Miss $270.00K Estimate
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.25) by 40 percent. This is unchanged from the same period last year. The company reported quarterly